LDB3 Gene Cardiomyopathy Dilated Type 1C NGS Genetic DNA Test
Introduction
The LDB3 Gene Cardiomyopathy Dilated Type 1C NGS Genetic DNA Test is a cutting-edge diagnostic tool that focuses on identifying genetic mutations in the LDB3 gene, which are linked to dilated cardiomyopathy (DCM). This condition is characterized by the enlargement of the heart’s chambers and a decrease in its ability to pump blood effectively. Early detection through genetic testing is crucial for managing the disease and preventing complications.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to analyze the LDB3 gene. It detects specific mutations that may predispose individuals to develop dilated cardiomyopathy, allowing for a better understanding of the patient’s condition and tailored treatment options.
Who Should Consider This Test
Individuals who should consider the LDB3 Gene Cardiomyopathy test include:
- Those with a family history of dilated cardiomyopathy or other cardiovascular disorders.
- Patients exhibiting symptoms such as fatigue, shortness of breath, or swelling in the legs.
- Individuals with known cardiovascular risk factors.
Benefits of Taking the Test
Taking the LDB3 Gene Cardiomyopathy test offers several benefits:
- Identifies genetic predispositions that can inform treatment strategies.
- Provides valuable information for family members regarding their risk.
- Facilitates early intervention to manage symptoms and improve quality of life.
Understanding Your Results
Results from the LDB3 Gene Cardiomyopathy test will indicate whether any mutations are present. A negative result may provide reassurance, while a positive result can guide further management and treatment plans. It is essential to discuss results with a healthcare provider for comprehensive understanding and next steps.
Test Name and Price
| Test Name | Discount Price | Regular Price |
|---|---|---|
| LDB3 Gene Cardiomyopathy Dilated Type 1C NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Additional Information
Turnaround time for results is approximately 3 to 4 weeks. The sample type required for this test includes blood, extracted DNA, or one drop of blood on an FTA card. Prior to testing, a clinical history of the patient is necessary, along with a genetic counseling session to create a pedigree chart of family members affected by LDB3 Gene Cardiomyopathy.
We have branches across Kenya and offer a home sample collection service for your convenience. To book the LDB3 Gene Cardiomyopathy Dilated Type 1C NGS Genetic DNA Test, please call or WhatsApp us at +254711564616.
